225 related articles for article (PubMed ID: 28739745)
1. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
2. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
3. Expression of aquaporin 1 in bladder uroepithelial cell carcinoma and its relevance to recurrence.
Liu J; Zhang WY; Ding DG
Asian Pac J Cancer Prev; 2015; 16(9):3973-6. PubMed ID: 25987071
[TBL] [Abstract][Full Text] [Related]
4. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
Du P; Ye L; Li H; Yang Y; Jiang WG
J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
[TBL] [Abstract][Full Text] [Related]
5. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.
Xie F; Ye L; Chen J; Wu N; Zhang Z; Yang Y; Zhang L; Jiang WG
J Transl Med; 2011 Jun; 9():95. PubMed ID: 21696600
[TBL] [Abstract][Full Text] [Related]
6. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
7. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.
Li XD; Zhang JX; Jiang LJ; Wang FW; Liu LL; Liao YJ; Jin XH; Chen WH; Chen X; Guo SJ; Zhou FJ; Zeng YX; Guan XY; Liu ZW; Xie D
Oncogene; 2016 Dec; 35(49):6281-6292. PubMed ID: 27181205
[TBL] [Abstract][Full Text] [Related]
9. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
[TBL] [Abstract][Full Text] [Related]
10. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Nie L; Gui Y; Cai Z
Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
[TBL] [Abstract][Full Text] [Related]
11. Effect of metastasis suppressor 1 on H1299 cells and its clinical significance in non-small cell lung cancer.
Zhao H; Xue J; Liu J; Liu Y; Cheng Y
Oncol Rep; 2016 Nov; 36(5):2814-2822. PubMed ID: 27634022
[TBL] [Abstract][Full Text] [Related]
12. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.
Liu K; Wang G; Ding H; Chen Y; Yu G; Wang J
BMC Cancer; 2010 Aug; 10():428. PubMed ID: 20712855
[TBL] [Abstract][Full Text] [Related]
14. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2015 Oct; 47(4):1429-39. PubMed ID: 26316204
[TBL] [Abstract][Full Text] [Related]
15. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu B; Chen Z; Re TJ; Zheng Q; Tang ZY; Huang XY
J Exp Clin Cancer Res; 2016 May; 35(1):85. PubMed ID: 27230279
[TBL] [Abstract][Full Text] [Related]
16. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
Zhang S; Qi Q
J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
[TBL] [Abstract][Full Text] [Related]
17. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
[TBL] [Abstract][Full Text] [Related]
18. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.
Theodorescu D; Sapinoso LM; Conaway MR; Oxford G; Hampton GM; Frierson HF
Clin Cancer Res; 2004 Jun; 10(11):3800-6. PubMed ID: 15173088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
